GeoVax Labs, Inc. - Common Stock - fluxo de caixa (NASDAQ:GOVX)

Financials

Fluxo de caixa operacional -2.75 M-11.2 M-19.03 M-25.17 M-24.68 M-21.47 M -19.05 M Fluxo de caixa de investimento -156.79 K-47.72 K-134.26 K-48.95 K-20.65 K-27.61 K -10.72 K Fluxo de caixa de financiamento 12.51 M12.78 M35.35 M4.06 M23.75 M19.08 M 12.89 M Fluxo de caixa livre -2.75 M-11.2 M-19.03 M-25.17 M-24.68 M-21.47 M -19.05 M

GeoVax Labs, Inc. - Common Stock

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated.

Notícias

GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marburg, Hantavirus, and Mpox Transcript

GOVX

Financials